Quercetin


Literature identifierStudy typeTest dosageEffective dosageEndocrine-mediated endpointsSystems-level perturbations
PMID:22121774IVR5 mg/kg/day 5 mg/kg/dayIncreased ovarian weightsReproductive endocrine-mediated perturbations
IVR45 mg/kg/day 45 mg/kg/dayAffects anogenital distanceReproductive endocrine-mediated perturbations
IVR45 mg/kg/day 45 mg/kg/dayAffects folliculogenesisReproductive endocrine-mediated perturbations
IVR45 mg/kg/day 45 mg/kg/dayDecreased LH levelsReproductive endocrine-mediated perturbations
IVR45 mg/kg/day 45 mg/kg/dayAbnormal estrous cyclesReproductive endocrine-mediated perturbations
IVR45 mg/kg/day 45 mg/kg/dayCancer phenotypeEndocrine-mediated cancer
IVR45 mg/kg/day 45 mg/kg/dayIncreased ovarian weightsReproductive endocrine-mediated perturbations
IVR45 mg/kg/day 45 mg/kg/dayDecreased FSH levelsReproductive endocrine-mediated perturbations
IVR25 mg/kg/day 25 mg/kg/dayIncreased ovarian weightsReproductive endocrine-mediated perturbations
PMID:23836117IVTH0.000002 - 0.000012 M 0.000008 MAffects sexual behaviorNeurological endocrine-mediated perturbations;Reproductive endocrine-mediated perturbations
PMID:24447974IVR50 mg/kg 50 mg/kgAlters thyroglobulin levelsMetabolic endocrine-mediated perturbations

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.